ZA200702318B - Nanobodies against amyloid-beta and polypeptides comprising the same for the treatment of degenerative neual diseases such as alzheimer's disease - Google Patents

Nanobodies against amyloid-beta and polypeptides comprising the same for the treatment of degenerative neual diseases such as alzheimer's disease

Info

Publication number
ZA200702318B
ZA200702318B ZA200702318A ZA200702318A ZA200702318B ZA 200702318 B ZA200702318 B ZA 200702318B ZA 200702318 A ZA200702318 A ZA 200702318A ZA 200702318 A ZA200702318 A ZA 200702318A ZA 200702318 B ZA200702318 B ZA 200702318B
Authority
ZA
South Africa
Prior art keywords
neual
degenerative
alzheimer
polypeptides
beta
Prior art date
Application number
ZA200702318A
Inventor
Lauwereys Marc
Van Leuven Fred
Van Der Auwera Ingrid
Wera Stefaan
Merchiers Pascal
Original Assignee
Ablynx Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ablynx Nv filed Critical Ablynx Nv
Publication of ZA200702318B publication Critical patent/ZA200702318B/en

Links

ZA200702318A 2004-10-13 2007-03-20 Nanobodies against amyloid-beta and polypeptides comprising the same for the treatment of degenerative neual diseases such as alzheimer's disease ZA200702318B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61814804P 2004-10-13 2004-10-13

Publications (1)

Publication Number Publication Date
ZA200702318B true ZA200702318B (en) 2008-11-26

Family

ID=38977040

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200702318A ZA200702318B (en) 2004-10-13 2007-03-20 Nanobodies against amyloid-beta and polypeptides comprising the same for the treatment of degenerative neual diseases such as alzheimer's disease

Country Status (2)

Country Link
CN (1) CN101076543A (en)
ZA (1) ZA200702318B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20130527A1 (en) 2010-03-03 2013-05-09 Boehringer Ingelheim Int BIPARATOPIC A-BETA BINDING POLYPEPTIDES
CN102284068A (en) * 2011-08-11 2011-12-21 华中科技大学同济医学院附属同济医院 Magnetic-resonance nano diagnosis reagent for senile plaques and optimizing method thereof
MX370725B (en) * 2012-10-15 2019-12-20 Medimmune Ltd Antibodies to amyloid beta.
EP2899208A1 (en) * 2014-01-28 2015-07-29 F.Hoffmann-La Roche Ag Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
SG11201705986QA (en) * 2015-01-29 2017-08-30 Technophage Investigação E Desenvolvimento Em Biotecnologia Sa Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
CN105542005B (en) * 2016-02-03 2018-11-09 大连理工大学 A kind of nano antibody of anti-human amyloid beta and its application
KR102114017B1 (en) * 2016-11-25 2020-05-22 주식회사 지뉴브 Composition for promoting differentiation of and protecting neural stem cells and method for inducing neural regeneration using same
CN111755070A (en) * 2019-03-29 2020-10-09 中山大学 Cascade decision system-based CircRNA function prediction method
CN114539393B (en) * 2020-11-25 2023-06-09 北京纽安博新逸生物科技有限公司 2019-novel coronavirus N protein single domain antibody and application thereof

Also Published As

Publication number Publication date
CN101076543A (en) 2007-11-21

Similar Documents

Publication Publication Date Title
IL182116A0 (en) Nanobodies tm against amyloid-beta and polypeptides comprising the same for the treatment of degenerative neural diseases such as alzheimer's disease
ZA200702318B (en) Nanobodies against amyloid-beta and polypeptides comprising the same for the treatment of degenerative neual diseases such as alzheimer's disease
EP1951892A4 (en) Antibody treatment of alzheimer's and related diseases
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
HK1215960A1 (en) Improved modalities for the treatment of degenerative diseases of the retina
HK1207821A1 (en) Improved modalities for the treatment of degenerative diseases of the retina
MX2007013626A (en) Antibodies directed against amyloid-beta peptide and methods using same.
IL222880A (en) Peptides and uses thereof in the treatment and diagnosis of diseases and pharmaceutical compositions comprising the same
PT2527315E (en) Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
WO2008097538A8 (en) Therapeutic agents
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
AU2003206413A1 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
ES2414872T8 (en) Combined therapy for the prevention or treatment of Alzheimer's disease and corresponding kit
WO2006035237A3 (en) Methods and compositions relating to alzheimer's disease
EP2091566A4 (en) Combination treatments for alzheimer's disease and similar diseases
EP1817050A4 (en) Diagnosis and treatment of alzheimer's disease
EP2011513A4 (en) Therapeutic agents for alzheimer's disease and cancer
WO2006020430A8 (en) Novel composition and methods for the treatment of immune related disease
AU2003254146A1 (en) Methods for the treatment of parkinson's disease
AU2003303141A1 (en) Hydroxypropyl amides for the treatment of alzheimer's disease
IL184849A0 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
IL188318A0 (en) Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue
WO2007048034A3 (en) Use of androgens for the treatment of parkinson' s disease
EP1832877A4 (en) Method of examining alzheimer's disease